Partial purification of a pramipexole-induced trophic activity directed at dopamine neurons in ventral mesencephalic cultures

Brain Research

Volumn 791, Issue 1-2, 1998, Pages 137-145

  Ling, Zao Dung ^a   Tong, Chong Wai ^a   Carvey, Paul M ^a  

^a Research Center for Brain Repair   (United States)

Author keywords

DA receptor; Dopamine; Neuroprotection; Purification; Trophic factor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; DOPAMINE 3 RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROTROPHIC FACTOR; PRAMIPEXOLE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DOPAMINERGIC NERVE CELL; MESENCEPHALON; NERVE CELL CULTURE; NERVE CELL GROWTH; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; RAT; ULTRACENTRIFUGATION;

ANIMALS; BENZOTHIAZOLES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DOPAMINE; DOPAMINE AGONISTS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MESENCEPHALON; MOLECULAR WEIGHT; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; THIAZOLES;

EID: 0344588872     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00088-2     Document Type: Article

References (32)

1. +) neurotoxicity against dopaminergic neurons in coculture of rat mesencephalon with their target on non-target regions. Neurosci. Res. 23:1995;55-63.
2. Ballagi A.E., Odin P., Othberg-Cederstrom A., Smits A., Duan W.M., Lindvall O., Funa K. Platelet-derived growth factor receptor expression after neural grafting in a rat model of Parkinson's disease. Cell Transplant. 3:1994;453-460.
3. Bouvier M.M., Mytilineou C. Basic fibroblast growth factor increases division and delays differentiation of dopamine precursors in vitro. J. Neurosci. 15:1995;7141-7149.
4. Cadoret M.A., Jaber M., Bloch B. Prenatal D1, D1b and D3 dopamine receptor gene expression in the rat forebrain: detection by reverse polymerase chain reaction. Neurosci. Lett. 155:1993;92-95.
5. Carvey, P.M., Ling, Z.D., The case for neuroprotection with dopamine agonists. Clin. Neuropharmacol. (1997) in press.
6. Carvey P.M., Pieri S.C., Ling Z.D. Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole. J. Neural Transm. 104:1997;209-228.
7. Carvey P.M., Tong C.W., Ling Z.D. D3-Mediated alterations in mesencephalic-derived neurotrophic activity. Soc. Neurosci. 23(1):1997;879. (Abstract).
8. Chernausek S.D. Insulin-like growth factor-I (IGF-I) production by astroglial cells: regulation and importance for epidermal growth factor-induced cell replication. J. Neurosci. Res. 34:1993;189-197.
9. Clarkson E.D., Zawada W.M., Freed C.R. GDNF reduces apoptosis in dopaminergic neurons in vitro. Neuroreport. 7:1995;145-149.
10. Dal Toso R., Giorgi O., Soranzo C., Kirschner G., Ferrari G., Favaron M., Benvegnu D., Presti D., Vicini S., Toffano G. Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures: I. Effects of cell density and of an adult mammalian striatal-derived neuronotrophic factor (SDNF). J. Neurosci. 8:1988;733-745.
11. Hao R., Norgren R.B., Lau Y.S., Pfeiffer R.F. Cerebrospinal fluid of Parkinson's disease patients inhibits the growth and function of dopaminergic neurons in culture. Neurology. 45:1995;138-142.
12. Hyman C., Juhasz M., Jackson C., Wright P., Ip N.Y., Lindsay R.M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14:1994;335-347.
13. Johansson M., Friedemann M., Hoffer B., Stromberg I. Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo. Exp. Neurol. 134:1995;25-34.
14. Kaddis F.G., Zawada W.M., Schaack J., Freed C.R. Conditioned medium from aged monkey fibroblasts stably expressing GDNF and BDNF improves survival of embryonic dopamine neurons in vitro. Cell Tissue Res. 286:1996;241-247.
15. + transport. Synapse. 15:1993;58-62.
16. Krieglstein K., Maysinger D., Unsicker K. The survival response of mesencephalic dopaminergic neurons to the neurotrophins BDNF and NT-4 requires priming with serum: comparison with members of the TGF-beta superfamily and characterization of the serum-free culture system. J. Neural Transm. Suppl. 47:1996;247-258.
17. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132. [see comments].
18. Lin L.F., Zhang T.J., Collins F., Armes L.G. Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63:1994;758-768.
19. Mayer E., Dunnett S.B., Pellitteri R., Fawcett J.W. Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons: I. Effects in vitro. Neuroscience. 56:1993;379-388.
20. 3 dopamine receptor in brain. Soc. Neurosci. 23(1):1997;270.9. (abstract).
21. Nielsen B.L., Bronw L.R. The basis for colored silver-protein complex formation in stained polyacrylamide gels. Anal. Biochem. 41:1984;311-315.
22. Ptak L.R., Hart K.R., Lin D., Carvey P.M. Isolation and manipulation of rostral mesencephalic tegmental progenitor cells from rat. Cell Transplant. 4:1995;335-342.
23. Rosenfeld R.D., Zeni L., Haniu M., Talvenheimo J., Radka S.F., Bennett L., Miller J.A., Welcher A.A. Purification and identification of brain-derived neurotrophic factor from human serum. Protein Expr. Purif. 6:1995;465-471.
24. Santa-Olalla J., Covarrubias L. Epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), and basic fibroblast growth factor (bFGF) differentially influence neural precursor cells of mouse embryonic mesencephalon. J. Neurosci. Res. 42:1995;172-183.
25. Seroogy K.B., Lundgren K.H., Tran T.M., Guthrie K.M., Isackson P.J., Gall C.M. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J. Comp. Neurol. 342:1994;321-334.
26. Spenger C., Hyman C., Studer L., Egli M., Evtouchenko L., Jackson C., Dahl-Jorgensen A., Lindsay R.M., Seiler R.W. Effects of BDNF on dopaminergic, serotonergic, and GABAergic neurons in cultures of human fetal ventral mesencephalon. Exp. Neurol. 133:1995;50-63.
27. Stromberg I., Bjorklund L., Johansson M., Tomac A., Collins F., Olson L., Hoffer B., Humpel C. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124:1993;401-412.
28. Thajeb P., Ling Z.D., Potter E.D., Carvey P.M. The effects of storage conditions and trophic supplementation on the survival of fetal mesencephalic cells. Cell Transplant. 6:1997;297-307.
29. Vu, T.Q., Ling, Z.D., Robie, H.C., Tong, C.W., Carvey, P.M., Pramipexole attenuates the dopaminergic biochemical, and neuronal cell loss induced by intraventricular 6-hydroxydopamine, Mov. Disord. (1997) submitted.
30. Yu S.J., Lo E.S., Cochran E.J., Lin D.H., Faselis C.J., Klawans H.L., Carvey P.M. Cerebrospinal fluid from patients with Parkinson's disease alters the survival of dopamine neurons in mesencephalic culture. Exp. Neurol. 126:1994;15-24.
31. Zawada W.M., Kirschman D.L., Cohen J.J., Heidenreich K.A., Freed C.R. Growth factors rescue embryonic dopamine neurons from programmed cell death. Exp. Neurol. 140:1996;60-67.
32. Zhou J., Bradford H.F., Stern G.M. The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment. Brain Res. 656:1994;147-156.